Skip to main content
. 2019 Jun 2;10(13):3054–3061. doi: 10.7150/jca.30486

Table 3.

Clinicopathologic characteristics of 36 patients with genital malformations who developed carcinomas

Variables Category N %
Parity (n=30) 0 10 33.3
1 8 26.7
≥2 12 40.0
Symptoms (n=31) Postcoital VB 4 12.9
Vaginal discharge 3 9.7
Intermenstrual VB 17 54.8
Periodic hematuria 1 3.2
Abnormal Pap smear 3 9.7
Postmenopausal VB 3 9.7
Sites of carcinoma Cervix 22 61.1
Vagina 10 27.8
Cervix and vagina 4 11.1
*FIGO stage of cervical carcinoma (n=25) 13 52.0
9 36.0
1 4.0
2 8.0
FIGO stage of vaginal carcinoma (n=10) 6 60.0
3 30.0
1 10.0
Pathology of cervix and vagina Adenocarcinoma 25 69.4
SCC 10 27.8
ASC 1 2.8
Urinary tract malformation URA 21 58.3
Others 2 5.6
No malformation 13 36.1
Genital tract malformation HWWS 8 22.2
Uterus didelphys 17 47.2
Others 11 30.6
Sites of carcinoma in patients with 2 cervices One cervix 9 45.0
(n=20) Two cervices 8 40.0
Vagina (no cervix) 3 15.0

*1 carcinoma in situ was not included

Abbreviations: ASC, adenosquamous carcinoma; HWWS, Herlyn-Werner-Wunderlich syndrome; PUMCH, Peking Union Medical College Hospital; SCC, squamous-cell carcinoma; URA, unilateral renal agenesis; VB, vaginal bleeding